Related Experiment Video
Updated: Apr 8, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Hepatitis: After HCV cure, HBV cure?
Julie Lucifora1, Christian Trepo1
1INSERM U1052, CNRS UMR_5286, Cancer Research Center of Lyon (CRCL), 151 Cours Albert Thomas, 69424 Lyon Cedex 03, France.
Current treatments efficiently control chronic HBV infection but they do not lead to its elimination. Now, Ebert and colleagues have shown that cellular inhibitor of apoptosis proteins (cIAPs) prevent TNF-mediated killing of infected hepatocytes and that cIAP antagonists might lead to HBV cure by promoting death of infected cells.
Current treatments efficiently control chronic HBV infection but they do not lead to its elimination. Now, Ebert and colleagues have shown that cellular inhibitor of apoptosis proteins (cIAPs) prevent TNF-mediated killing of infected hepatocytes and that cIAP antagonists might lead to HBV cure by promoting death of infected cells.
More Related Videos
Related Concept Videos
Hepatitis
Retrovirus Life Cycles
Viruses with RNA Genomes

